Clinical trials: Right Heart Failure

Rift Valley Fever

Safety and Immunogenicity Study of Rift Valley Fever Vaccine

• Completed
• Age: 17 years and older
• Phase 2
• Vaccines
• Results posted

This study is designed to determine the safety and immunogenicity of a Rift Valley Fever (RVF) Vaccine

Trial name

RVF (NCT00584194)

Testing

TSI-GSD 200 RVF Vaccine

Where

United States

Volunteers

278 people, healthy volunteers welcome

Sponsor

U.S. Army Medical Research and Development Command